Search Results

Fluid Management May Improve Sepsis Outcomes

Sepsis is a life-threatening condition that occurs when the body damages its own organs while trying to fight an infection; it’s an infection response out of control and its impact is vast.  

Baxter Issues Urgent Medical Device Correction for Life2000 Ventilation System Due to Potential For Patient Desaturation When Connected With An Oxygen Concentrator

Baxter International Inc. announced today it has issued an Urgent Medical Device Correction for the Life2000 Ventilation System due to the potential for patient oxygen desaturation (low blood oxygen) events that can occur under certain conditions when the Life2000 system is connected with a third-party oxygen concentrator. The Life2000 system is manufactured by Hillrom, which was acquired by Baxter in late 2021.

Destined to Advocate for Diversity, Equity and Inclusion

Meet Rachel, co-president of our Alliance for Baxter Women business resource group

Kidney Patients Choose to Begin Again

Being diagnosed with kidney disease can seem overwhelming and feel like everything changed at once. An essential first step to helping patients start their therapy strong is empowering them to proactively participate with their healthcare professional team in the decision-making process about their journey. The next step is supporting their access to innovative therapy options designed to provide differentiated care.

At a Glance: 2023 Hospital Trends

The COVID-19 pandemic turned the healthcare ecosystem upside down. Then came economic uncertainty. From staffing shortages to increased operating expenses, to volatility in product supply and unpredictable patient volumes, the balancing act faced by hospitals is more complex than ever.

Cardiac Monitoring Patch Helps Mom’s Life Stay on Beat

Since she was a child, Lauryn—a Baxter sales executive—managed a cardiovascular condition that caused her heart to beat irregularly fast and took her away from the moments that mattered most. When she was prescribed and used the diagnostic product she sold, she obtained a precise diagnosis that led to a lasting treatment.

A Grassroots and Global Approach to a Business Resource Group

Meet Bruce, a territory manager for our Front Line Care business, and co-president of Baxter's Black Professional Alliance  

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on April 3, 2023, to shareholders of record as of February 24, 2023. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter

Baxter Reports Fourth-Quarter and Full-Year 2022 Results

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2022, and provided its financial guidance for full-year and first-quarter 2023. 

Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure

Miromatrix Medical Inc. (NASDAQ: MIRO) and Baxter International Inc. (NYSE:BAX) today announced a collaborative research agreement to help support additional treatment options for patients with acute liver failure (ALF) in need of organ support therapies. As part of the collaboration, Miromatrix has created a new liver therapy called miroliverELAP that combines a Miromatrix single-use bioengineered liver with Baxter’s PrisMax system.